US Stock MarketDetailed Quotes

XFOR X4 Pharmaceuticals

Watchlist
  • 0.804
  • -0.002-0.22%
Close Dec 27 16:00 ET
  • 0.840
  • +0.036+4.49%
Post 19:57 ET
137.10MMarket Cap-10.05P/E (TTM)

X4 Pharmaceuticals Key Stats

X4 Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 13, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
1.69M
560.00K
-1.13M
Miss Est.
--
--
-66.79%
EPS
-0.17
-0.18
-<0.01
Miss Est.
-1645.45%
-1700.00%
-4.17%
Buy

Dec 8, 2024

X4 Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.526M--
--2024/Q4-- / 1.065M--
Nov 13, 20242024/Q3560.000K / 1.686M--
Aug 8, 20242024/Q2563.000K / 15.265M--
May 7, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.526M--
--2024/Q4-- / 1.065M--
Nov 13, 20242024/Q3560.000K / 1.686M--
Aug 8, 20242024/Q2563.000K / 15.265M--
May 7, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

X4 Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 8, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data